Philips installs leading digital imaging solutions at new Central Acute Services Building of Westmead Hospital in Sydney Aust...
April 19 2021 - 04:00AM
Philips installs leading digital imaging solutions at new Central
Acute Services Building of Westmead Hospital in Sydney Australia
April 19, 2021
- New state-of-the-art Central Acute Services Building at
Westmead Hospital features next-generation diagnostic and
neurovascular imaging solutions, aimed at improving the efficiency
and accuracy of care delivered to trauma patients requiring
critical care
- Installation of first Philips Magnetic Resonance - Ingenia
MR-OR - intraoperative systems in Australia and New Zealand
enhances speed and efficiency for critical neuro cases
Amsterdam, the Netherlands and Sydney Australia
– Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in
health technology, has announced the successful installation of its
most advanced digital diagnostic and interventional neurovascular
imaging solutions in the brand new Central Acute Services Building
at Westmead Hospital (Sydney, Australia). Fast-tracked under the
New South Wales (NSW) Government’s COVID-19 response plan, this new
state-of-the-art integrated health, education, and medical research
facility features a new digital imaging enabled operating room and
expanded imaging services.
MR imaging during neurosurgeryThe centerpiece
of a one billion Australian Dollar Westmead Health Precinct
redevelopment project, the Central Acute Services Building is now
equipped with Philips’ most advanced medical imaging technology,
including Australia’s first two Philips Magnetic Resonance -
Ingenia MR-OR - intraoperative systems. Part of a sterile dual-room
concept that offers an operating suite directly connected to a
scanning room, the MR-OR systems will provide MR imaging during
neurosurgery. This will help enable closer collaboration between
surgeons and radiologists, delivering greater speed, efficiency and
clinical confidence. With up-to-date MR information at virtually
any time during surgical procedures clinicians can make real-time
adjustments to treatment during these procedure. For critical neuro
cases such as stroke and acute trauma, where fast diagnosis and
treatment are essential, these combined capabilities help to
optimize patient outcomes.
Speed and accuracy The new Central Acute
Services Building installation also includes Philips Image Guided
Therapy System - Azurion biplane -, allowing clinicians to perform
an array of cardiac and vascular interventions. Specifically
selected by Westmead Hospital’s Interventional Neuro, Vascular and
Surgical teams for its speed and accuracy in trauma care, this
industry leading image-guided therapy platform allows clinicians to
confidently perform procedures by offering them a superior user
experience that lets them optimize lab performance and workflows to
suit their personal preferences and make fast, informed decisions
to provide superior care for their patients.
“It is very encouraging to see public health departments
adopting technologies and workflows aligned to a more sustainable
and robust healthcare future,” said Matt Moran, Managing Director
of Philips Australia and New Zealand. “The Westmead Health Precinct
is a leading example of what is possible in terms of
next-generation health delivery.”
Westmead Health Precinct is one of the largest health,
education, research and training providers in Australia. Staff and
patients began relocating to the new facility in February, 2021,
with both the adult and children’s emergency departments now open
to the public. In addition to Philips Magnetic Resonance – Ingenia
MR-OR – and Image Guided Therapy System – Azurion biplane –,
Philips has also provided Westmead Hospital’s Central Acute
Services Building with:
- Image Guided Therapy System – Azurion FlexMove
- Radiography – DigitalDiagnost C90
- Image Guided Therapy Mobile Mobile C-arm System – Zenition
70
- Mobile Radiography – MobileDiagnost wDR 2.1
For further information, please contact:
Joost MalthaPhilips Global Press OfficeTel.: +31 6 10 55 81
16E-mail: joost.maltha@philips.com
Sarah Al-HashimiPhilips AustraliaTel. : +61 40 21 17 768 E-mail:
Sarah.AL-Hashimi@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2020 sales of EUR 19.5 billion and
employs approximately 82,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Philips Magnetic Resonance – Ingenia MR-OR - interoperative
system
- Philips Image Guided Therapy System - Azurion biplane -
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Mar 2023 to Mar 2024